{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:05Z","timestamp":1791925385117,"version":"4.3.4"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.5026","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:40:07Z","timestamp":1648766407000},"page":"e225026","source":"Crossref","is-referenced-by-count":11,"title":["Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes"],"prefix":"10.1001","volume":"5","author":[{"given":"Monique M.","family":"Hedderson","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"},{"name":"Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Badon","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Pimentel","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Regenstein","sequence":"additional","affiliation":[{"name":"The Permanente Medical Group, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assiamira","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Neugebauer","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"zoi220172r1","doi-asserted-by":"publisher","DOI":"10.5888\/pcd11.130415","article-title":"Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010.","volume":"11","author":"DeSisto","year":"2014","journal-title":"Prev Chronic Dis"},{"key":"zoi220172r2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2393-12-23","article-title":"Gestational diabetes and pregnancy outcomes\u2014a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria.","volume":"12","author":"Wendland","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"zoi220172r3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ajog.2004.11.039","article-title":"Gestational diabetes: the consequences of not treating.","volume":"192","author":"Langer","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi220172r4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ecl.2005.09.007","article-title":"Management of gestational diabetes: pharmacologic treatment options and glycemic control.","volume":"35","author":"Langer","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2 Pt 1","key":"zoi220172r5","first-page":"406","article-title":"Practice Bulletin No. 137: gestational diabetes mellitus.","volume":"122","author":"Bulletins-Obstetrics CoP","year":"2013","journal-title":"Obstet Gynecol"},{"key":"zoi220172r6","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.ijgo.2008.11.027","article-title":"Pregnancy and diabetes scenario around the world: Africa.","volume":"104","author":"Coetzee","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"zoi220172r7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/AOG.0000000000000285","article-title":"Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011.","volume":"123","author":"Camelo Castillo","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"1","key":"zoi220172r8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00404-019-05430-3","article-title":"Can glyburide be advocated over subcutaneous insulin for perinatal outcomes of women with gestational diabetes? a systematic review and meta-analysis.","volume":"301","author":"Helal","year":"2020","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"zoi220172r9","doi-asserted-by":"publisher","first-page":"367.e1","DOI":"10.1016\/j.ajog.2018.06.013","article-title":"A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes.","volume":"219","author":"Barbour","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"zoi220172r10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"3","key":"zoi220172r12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/01.AOG.0000113623.18286.20","article-title":"An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000.","volume":"103","author":"Ferrara","year":"2004","journal-title":"Obstet Gynecol"},{"key":"zoi220172r13","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.2337\/dc07-s225","article-title":"Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus.","volume":"30","author":"Metzger","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"zoi220172r14","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","article-title":"ACOG Practice Bulletin No. 190: gestational diabetes mellitus.","volume":"131","author":"ACOG Practice Bulletin No","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"9596","key":"zoi220172r15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"zoi220172r16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00019514-199705040-00003","article-title":"Rapid retrieval of neonatal outcomes data: the Kaiser Permanente Neonatal Minimum Data Set.","volume":"5","author":"Escobar","year":"1997","journal-title":"Qual Manag Health Care"},{"issue":"3","key":"zoi220172r17","doi-asserted-by":"publisher","first-page":"240.e1","DOI":"10.1016\/j.ajog.2010.10.907","article-title":"The risk of large size for gestational age across increasing categories of glycemia in pregnancy.","volume":"204","author":"Ehrlich","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi220172r18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1740774511420743","article-title":"Beyond the intention-to-treat in comparative effectiveness research.","volume":"9","author":"Hern\u00e1n","year":"2012","journal-title":"Clin Trials"},{"issue":"14","key":"zoi220172r19","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMsm1605385","article-title":"Per-protocol analyses of pragmatic trials.","volume":"377","author":"Hern\u00e1n","year":"2017","journal-title":"N Engl J Med"},{"issue":"1-2","key":"zoi220172r22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1005285815569","article-title":"Association, causation, and marginal structural models.","volume":"121","author":"Robins","year":"1999","journal-title":"Synthese"},{"issue":"9","key":"zoi220172r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.26605","article-title":"Association of cardiovascular outcomes and mortality with sustained long-acting insulin only vs long-acting plus short-acting insulin treatment.","volume":"4","author":"Schroeder","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi220172r24","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1309","article-title":"Super learner.","volume":"6","author":"van der Laan","year":"2007","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"5","key":"zoi220172r25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/sim.6377","article-title":"High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.","volume":"34","author":"Neugebauer","year":"2015","journal-title":"Stat Med"},{"issue":"4","key":"zoi220172r26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/EDE.0b013e3181a82501","article-title":"Exhaustion, automation, theory, and confounding.","volume":"20","author":"Joffe","year":"2009","journal-title":"Epidemiology"},{"key":"zoi220172r27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/01621459.1997.10473608","article-title":"Polychotomous regression.","volume":"92","author":"Kooperberg","year":"1997","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"zoi220172r30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1214\/09-AOAS285","article-title":"BART: bayesian additive regression trees.","volume":"4","author":"Chipman","year":"2010","journal-title":"Ann Appl Stat"},{"issue":"6","key":"zoi220172r31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models.","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi220172r32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0962280210386207","article-title":"Diagnosing and responding to violations in the positivity assumption.","volume":"21","author":"Petersen","year":"2012","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"zoi220172r34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward.","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"issue":"1","key":"zoi220172r35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0962280208092345","article-title":"Observation plans in longitudinal studies with time-varying treatments.","volume":"18","author":"Hern\u00e1n","year":"2009","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"zoi220172r37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/bimj.v62.2","article-title":"Estimating treatment effects with partially observed covariates using outcome regression with missing indicators.","volume":"62","author":"Blake","year":"2020","journal-title":"Biom J"},{"issue":"9","key":"zoi220172r38","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.2337\/diacare.20.9.1396","article-title":"Excess costs of medical care for patients with diabetes in a managed care population.","volume":"20","author":"Selby","year":"1997","journal-title":"Diabetes Care"},{"issue":"19","key":"zoi220172r39","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1001\/jama.287.19.2519","article-title":"Ethnic disparities in diabetic complications in an insured population.","volume":"287","author":"Karter","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"zoi220172r40","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jamapediatrics.2015.74","article-title":"Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes.","volume":"169","author":"Camelo Castillo","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"17","key":"zoi220172r41","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jama.2018.4561","article-title":"Insulin vs glyburide for gestational diabetes.","volume":"319","author":"Coustan","year":"2018","journal-title":"JAMA"},{"issue":"17","key":"zoi220172r42","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1001\/jama.2018.4072","article-title":"Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: a randomized clinical trial.","volume":"319","author":"S\u00e9nat","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"zoi220172r43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232002","article-title":"Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk.","volume":"15","author":"Bouchghoul","year":"2020","journal-title":"PLoS One"},{"key":"zoi220172r44","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.2337\/dc20-S014","article-title":"14. Management of diabetes in pregnancy: Standards of Medical Care in Diabetes-2020.","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"zoi220172r45","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","article-title":"A structural approach to selection bias.","volume":"15","author":"Hern\u00e1n","year":"2004","journal-title":"Epidemiology"},{"key":"zoi220172r21","author":"Robins","year":"1998"},{"key":"zoi220172r33","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511802256","volume-title":"Asymptotic Statistics","author":"van der Vaart","year":"1998"},{"key":"zoi220172r11","unstructured":"Gordon? NP. Similarity of adult Kaiser Permanente members to the adult population in Kaiser Permanente\u2019s Northern California service area: comparisons based on the 2017\/2018 cycle of the California Health Interview Survey. November 8, 2020. Accessed February 23, 2022. https:\/\/divisionofresearch.kaiserpermanente.org\/projects\/memberhealthsurvey\/SiteCollectionDocuments\/compare_kp_ncal_chis2017-18.pdf"},{"key":"zoi220172r20","unstructured":"Leong? TK, Tababa? GH, Yang? JM, Zhu? Z, Neugebauer? RS. Software for causal inference research. Accessed February 23, 2022. https:\/\/divisionofresearch.kaiserpermanente.org\/projects\/biostatistics\/causalinferencesoftware"},{"key":"zoi220172r28","unstructured":"Chen? T, Guestrin? C. XGBoost: a scalable tree boosting system. Accessed February 23, 2022. https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/2939672.2939785"},{"key":"zoi220172r29","unstructured":"Chen? T, Hem? T, Benesty? M, Khotilovich? V, Tang? Y. xgboost: Extreme gradient boosting R package. Accessed March 3, 2022. https:\/\/github.com\/dmlc\/xgboost"},{"key":"zoi220172r36","unstructured":"Kreif? N, Sofrygin? O, Schmittdiel? JA, . Evaluation of adaptive treatment strategies in an observational study where time-varying covariates are not monitored systematically.? arXiv. Preprint posted online June 28, 2018. Accessed March 14, 2022. https:\/\/arxiv.org\/abs\/1806.11153"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2790574\/hedderson_2022_oi_220172_1650295272.95566.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T15:12:33Z","timestamp":1650553953000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2790574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.5026","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]}}}